RPG Life Sciences Launches Strategic API Growth Initiative
RPG Life Sciences has launched a strategic Active Pharmaceutical Ingredient (API) initiative, with InvAscent investing in RPG Active Pharma and the unit acquiring Actis Generics.
Actis Generics | 31/07/2026 | By News Bureau | 156
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy